سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Nanoencapsulation of Phthalate from Melastomastrum Capitatum (Fern.) in Chitosan-Nps as a Target Mediated Drug Delivery for Multi-Drug Resistant Pathogen

Publish Year: 1400
Type: Journal paper
Language: English
View: 199

This Paper With 21 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_IJABBR-9-2_004

Index date: 29 May 2021

Nanoencapsulation of Phthalate from Melastomastrum Capitatum (Fern.) in Chitosan-Nps as a Target Mediated Drug Delivery for Multi-Drug Resistant Pathogen abstract

Background: Chitosan nanoparticle (chitosan-NPs) is a polymer obtained from the exoskeletons of crustaceans, and has been applied recently as a carrier for many drug agents. Multi-drug resistance has been the major set-back in the treatment of microbial infections globally. Methods: Dibutyl phthalate (DBP) isolated from Melastomastrum capitatum leaves was encapsulated in chitosan-NPs and its antimicrobial activity was evaluated on selected multi-drug resistant pathogens. The isolated phthalate was characterized by FTIR, NMR and GC-MS. Chitosan-NPs encapsulated phthalate was prepared by ionic gelation of glutaraldehyde cross-linker. Antimicrobial activity of nano encapsulated drugs was carried by agar well diffusion at 0.5 µg/mL concentration. In vivo activity of nano encapsulated drugs were determined in thirty Swiss albino rats weighing 100-150g. Chitosan-NPs encapsulated treatment groups were administered at 0.5 µg/mL (i.p.) as compared with ciprofloxacin positive control group at 2.5 µg/mL. Results: Chitosan-NPs encapsulated phthalate showed the strongest zones of inhibition against VRE ATCC 29212, MRSA NCTC 13435, Candida albicans ATCC 19231, and Clostridiodes difficile NCTC14385. Significant inhibition of bacterial growths was achieved by CSDBP encapsulated phthalate both in vitro and in vivo studies due to low concentrations in ALT, ALP, AST and creatinine, and high volume of WBC in rats. Non-Fickian drug release was observed by the formulations. Conclusion: The study showed that chitosan-NPs mediated drug delivery exhibited strong antimicrobial activity with sustained release against multi-drug microbes in this study. This is promising, and can be employed as mediation for multi-drug resistant pathogens.

Nanoencapsulation of Phthalate from Melastomastrum Capitatum (Fern.) in Chitosan-Nps as a Target Mediated Drug Delivery for Multi-Drug Resistant Pathogen Keywords:

Nanoencapsulation of Phthalate from Melastomastrum Capitatum (Fern.) in Chitosan-Nps as a Target Mediated Drug Delivery for Multi-Drug Resistant Pathogen authors

- -

Department of Pharmacognosy, Faculty of Pharmacy, University of Maiduguri, Maiduguri, Nigeria

- -

Department of Pharmacognosy and Traditional Medicine, Faculty of Pharmacy Delta State University, Abraka, Nigeria

- -

Department of Microbiology, Faculty of Natural Sciences, Kogi State University Anyigba, Nigeria

- -

Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmacy, University of Maiduguri, Nigeria

- -

Department of Biological Sciences, Faculty of Science, Taraba State University Jalingo, Jalingo, Nigeria

- -

Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, Zaria, Nigeria

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs D ...
World Health Organization. (۲۰۱۴). Antimicrobial resistance: global report on surveillance ...
Gomez JE, Kaufmann-Malaga BB, Wivagg CN, Kim PB, Silvis MR, ...
Rolo J, Worning P, Boye Nielsen J, Sobral R, Bowden ...
Ziha-Zarifi I, Llanes C, Kohler T, Pechere JC, Plesiat P. ...
Unemo M, Golparian D, Sánchez-Busó L, Grad Y, Jacobsson S, ...
Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, ...
Lee JYH, Monk IR, Gonçalves da Silva A, Seemann T, ...
O’Neill GL, Murchan S, Gil-Setas A, Aucken HM. (۲۰۰۱). Identification ...
WHO (۲۰۱۵). Global plan for antimicrobial resistance. Archivedfrom the original ...
Dheer D, Gupta JPN, Shankar R. (۲۰۱۸). Tacrolimus: An updated ...
Cheba BA. (۲۰۱۱). Chitin and chitosan: marine biopolymers with unique ...
Badawy MEI, Rabea EI. (۲۰۱۱). A biopolymer chitosan and its ...
Rosso AP, Martinelli M. (۲۰۲۰). Preparation and characterization of dendronized ...
Molpeceres J, Aberturas MR, Guzman M. (۲۰۰۰). Biodegradable nanoparticles as ...
Aminabhavi TM, Dharupaneedi SP, More AU. (۲۰۱۷). The role of ...
Adhikari HS, Yadav PN. (۲۰۱۸). Anticancer activity of chitosan, chitosan ...
Saeidnia S. (۲۰۱۴). Phthalates, Encyclopaedia of toxicology ۳rd Edition ...
Occupational Safety and Health Administration (OSHA), Phthalic acid. Available online ...
Lotha G (۲۰۱۳). Phthalic acid chemical compound safety. Britannica ...
Hiraiwa Y, Morinaka A, Fukushima T, Kudo T. (۲۰۰۹). Metallo-β-lactamase ...
Cassano R, De-Amicis F, Servidio C, Curcio F, Trombino S. ...
Sasidharan S, Chen Y, Saravanan D, Sundram KM, Latha LY. ...
Saraswathi SV, Saravanan D, Santhakumar K. (۲۰۱۷). Isolation of quercetin ...
Alfarra HY, Muhammd NO. (۲۰۱۴). HPLC separation and isolation of ...
Gini TG, Jothi GJ. (۲۰۱۸). Column chromatography and HPLC analysis ...
Ukwubile CA, Ahmed A, Katsayal UA, Ya'u J, Mejida S. ...
Lazaridou M, Christodoulou E, Nerantzaki M, Kostoglou M, Lambropoulou DA, ...
Naskar S, Sharma S, Kuotsu K. (۲۰۱۹). Chitosan-based nanoparticles: An ...
Shariatinia Z. (۲۰۲۰). Biopolymeric Nanocomposites in Drug Delivery. In: Nayak ...
Ramachandran R, Shanmughave P. (۲۰۱۰). Preparation and characterization of biopolymeric ...
The European Committee on Antimicrobial Susceptibility Testing (EUCAST), www.eucast.org ...
Mohammed FADL, Alaasar MM. (۲۰۱۸). In Vitro Susceptibility Testing of ...
Clinical and Laboratory Standards Institute (CLSI) (۲۰۱۲). Methods for antimicrobial ...
Andrews JM. (۲۰۰۱). Determination of minimum inhibitory concentrations. J. Antimicrob ...
Escárcega-González CE, Garza-Cervantes JA,Vazquez-Rodríguez A, Montelongo-Peralta LZ, Treviño-Gonzalez MT, Barriga-Castro ...
نمایش کامل مراجع